Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) December 17, 2022checkorphan Learn more about: Mast Cell Disease Related Clinical Trial Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) Masitinib for the Treatment of Severe Mast Cell Activation Syndrome Mast Cell Activation Test in Allergic Disease Recruitment InformationAdministrative Informations
